Advanced Enzyme FY26 Net Profit Rises 29% YoY

Approved audited standalone and consolidated financial results for FY26 and Q4 FY26, reporting a 29% YoY rise in consolidated net profit to ₹1,736.08 million.
Recommended a final dividend of ₹1.35 per share (67.5% on face value of ₹2) for FY26, subject to shareholder approval at the 37th AGM.
Reappointed Mr. Mukund Kabra as Whole-time Director and appointed Mr. Pradip Shah as an Independent Director, both subject to shareholder approval.
Allotted 49,350 equity shares pursuant to ESOP exercise, increasing paid-up capital to ₹22,39,52,300 comprising 11,19,76,150 shares.